Green Cross Medical Science CEO Yeongeun Kim Buys 2,500 Shares, Raising Stake to 0.17%

Green Cross Medical Science CEO Yeongeun Kim acquired an additional 2,500 common shares on June 12, 2026 via open market purchase at 3,375 KRW per share.
His total holdings rose from 38,000 to 40,500 shares, but due to an increase in total outstanding shares from the exercise of stock purchase rights, his ownership ratio slightly dipped from 0.18% to 0.17%.
The current stock price stands at 3,415 KRW, slightly above the acquisition price. This small insider buy signals management confidence but has limited impact on the stock price.
[AI Summary]The CEO's minor open market purchase is a positive signal of insider confidence, but its effect is muted by dilution from newly issued shares. Investors should note the potential dilution risk from the exercise of stock purchase rights.